Thu Sep 26 12:53:42 UTC 2024: ## Impact BioMedical Secures New Patent for Natural Insect Repellent, Aims for Market Launch

**HOUSTON, TX** – Impact BioMedical Inc. (OTC: IBO) has been granted a new U.S. patent for its innovative insect repelling composition, further strengthening its 3F™ technology platform. The company’s plant-based formulations, which aim to reduce insect landings and bites, now boast two patents: U.S. Patent No. 11,985,973 and U.S. Patent No. 11,246,310.

The newly patented technology operates by blocking insect olfactory receptors, effectively rendering humans invisible to them. This could translate into a natural human insect repellent with potential applications in detergents, shampoos, and lotions.

With vector-borne diseases accounting for 17% of global infectious diseases, according to the World Health Organization, this technology presents a significant opportunity in the market.

Impact BioMedical CEO, Frank D. Heuszel, expressed enthusiasm about the patent, highlighting the company’s commitment to addressing healthcare needs. He also announced plans to accelerate discussions with potential partners to bring the technology to market both domestically and internationally.

**Financial Performance and Investor Perspective**

Impact BioMedical currently holds a market capitalization of $28.63 million. Despite the promising technological advancements, the company has not yet achieved profitability in the past twelve months, with a negative P/E ratio of -6.26.

Recent stock performance has seen a decline, trading near its 52-week low at $2.60. This decline is further reflected in the one-week price total return of -8.33%. The InvestingPro Fair Value estimate for Impact BioMedical stands at $1.79, suggesting a potential overvaluation of the stock.

Investors should consider the company’s financial challenges, including weak gross profit margins and short-term obligations exceeding liquid assets, alongside its technological breakthroughs.

For a more comprehensive analysis of Impact BioMedical Inc., visit InvestingPro.

Read More